Successor

Predecessor

January 1, 2019 – December 31, 2019

August 28, 2018-December 31, 2018

January 1, 2018-August 27, 2018

Numerator for basic and diluted net income (loss) per share:

Net income (loss) attributable to Sanara MedTech

$

(2,814,088

)

$

138,286

$

37,178

Series C Preferred Stock dividends

-

(28,061

)

Series C Preferred Stock inducement dividends

-

(103,197

)

Basic net income (loss) attributable to Sanara MedTech common shareholders

$

(2,814,088

)

$

138,286

$

(94,080

)

Denominator for basic and diluted net income (loss) per share:

Weighted average shares used to compute diluted net income (loss) per share

2,132,745

-

2,068,941

Basic and diluted net income (loss) per share attributable to common shareholders

$

(1.32

)

$

-

$

(0.05

)